NCT01751399 - A Single Dose Study of LY2605541 in Participants With Liver Impairment | Biotech Hunter

Enrollment

35

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Healthy VolunteersHepatic InsufficiencyDiabetes Mellitus, Type 2

Interventions

DRUG

LY2605541

Trial Locations (2)

8230

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Balatonfüred

81241

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Munich